Bull&Bear | Walgreens, Microvast, and Constellation Lead Bullish Surge; IGM, Dyne, and Gorilla Face Sharp Declines

In the realm of bullish stocks, Walgreens Boots Alliance (WBA) surged by 27.55%. The company released its quarterly earnings report, showcasing positive financial performance that likely contributed to this significant increase in share value.

Microvast Holdings (MVST) experienced a 25.67% rise. The company announced a major breakthrough in solid-state battery technology, which likely fueled investor optimism and drove the stock price upward.

Constellation Energy (CEG) saw its stock climb by 25.16%. The American energy giant agreed to acquire Calpine for $16.4 billion. This strategic acquisition is anticipated to enhance Constellation Energy’s market position and growth prospects, encouraging investors to buy into the stock.

Jayud Global Currency Logistics Co. Ltd. (JYD) rose by 23.65%. The company's board approved the appointment of James Chen as co-CEO, which may have been perceived positively by investors, contributing to the increase in its stock price.

Amprius Technologies (AMPX) had an 18.32% increase. Northland Securities maintained a buy rating on Amprius Technologies and raised its target price from $4.00 per share to $10.00 per share, boosting investor confidence and leading to the stock's rise.

On the bearish side of the stock market, IGM Biosciences (IGMS) dropped by 66.29%, continuing a two-day decline that totaled a 69.26% decrease. This trend followed a downward adjustment of the target price by Truist Securities from $12.00 to $2.00 per share, significantly affecting investor sentiment.

Dyne (DYN) fell by 31.15%, marking a five-day downward streak with a total drop of 37.67%. The stock's decline in Friday trading was primarily driven by the company's reporting of substantial quarterly losses, raising concerns among investors about its financial health.

Gorilla Technology Group Inc. (GRRR) experienced a 30.36% decline over the same period, extending its five-day drop to 52.12%. Influenced by recent economic data and rising yields, the entire market, particularly the tech sector, has seen weakened trading activity. This drop was exacerbated by investor unease following the recent pullback in Nvidia stock.

Inozyme Pharma (INZY) saw its shares decline by 28.75% after a four-day decrease totaling 35.02%. The company plans to initiate the Aspire trial in early 2026, but this announcement appears to have not alleviated investor concerns in the short term.

Currency Group (CURR) fell by 27.04%. On Wednesday, the company's stock fell as market concerns about its financial health intensified. Reports suggest that Currency Group is facing liquidity issues, which could impact its ability to meet short-term debt obligations. This negative news eroded investor confidence, contributing to the stock's decline.